Business · 15/02/2023Updated: 10/17/2026 · 1 min read
FDA Issues Final Guidance on Compounding Ibuprofen Oral Suspension Products
Summary
The FDA has released a final guidance on compounding certain ibuprofen oral suspension products for hospitals, health systems, and pharmacies, updating its priorities for outsourcing facilities and pharmacy dispensing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →